Overview

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

Status:
NOT_YET_RECRUITING
Trial end date:
2026-05-29
Target enrollment:
Participant gender:
Summary
Drug-drug interaction study between Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone
Phase:
PHASE1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Treatments:
Buprenorphine
Naloxone